Antiamoebic Drugs
... Cardiac arrhythmias, heart failure, hypotension (serious toxicity) • Caution: the drug should not be used in patients with cardiac or renal disease, in young children, or in pregnancy. ...
... Cardiac arrhythmias, heart failure, hypotension (serious toxicity) • Caution: the drug should not be used in patients with cardiac or renal disease, in young children, or in pregnancy. ...
dexamethasone - DavisPlus
... treated for tuberculous meningitis); Known alcohol or bisulfite hypersensitivity or intolerance (some products contain these and should be avoided in susceptible patients); Lactation: Avoid chronic use. Use Cautiously in: Chronic treatment (will lead to adrenal suppression; use lowest possible dose ...
... treated for tuberculous meningitis); Known alcohol or bisulfite hypersensitivity or intolerance (some products contain these and should be avoided in susceptible patients); Lactation: Avoid chronic use. Use Cautiously in: Chronic treatment (will lead to adrenal suppression; use lowest possible dose ...
harnessing-the-gut-microbiome-presentation
... Bowel prep of any kind was not needed Donor did not affect outcome Non-related universal donors worked Cure was durable – No additional occurrences in successful patients out to 6 months with/without antibiotic treatment for other indications ...
... Bowel prep of any kind was not needed Donor did not affect outcome Non-related universal donors worked Cure was durable – No additional occurrences in successful patients out to 6 months with/without antibiotic treatment for other indications ...
Heart Failure:
... therapy but due to their side effect profiles are not well tolerated by the elderly. ...
... therapy but due to their side effect profiles are not well tolerated by the elderly. ...
Dose Titration: - The Therapeutics Initiative
... For those patients who do not require an immediate response (hypertension, NIDDM, osteoarthritis, hyperlipidemia), start with a dose that is 1/4 to 1/2 the recommended starting dose in the CPS. Then titrate the daily dose every two to four weeks (if this is a useful interval) to the desired effect. ...
... For those patients who do not require an immediate response (hypertension, NIDDM, osteoarthritis, hyperlipidemia), start with a dose that is 1/4 to 1/2 the recommended starting dose in the CPS. Then titrate the daily dose every two to four weeks (if this is a useful interval) to the desired effect. ...
September 2010, Number 8
... Further studies are necessary to analyze the effectiveness of entacapone on patients with Parkinson’s disease longer than 5-10 years. In preclinical studies, dyskinesia, hyperkinesia, nausea, urine discoloration, diarrhea, and abdominal pain were not only the most common adverse events (greater than ...
... Further studies are necessary to analyze the effectiveness of entacapone on patients with Parkinson’s disease longer than 5-10 years. In preclinical studies, dyskinesia, hyperkinesia, nausea, urine discoloration, diarrhea, and abdominal pain were not only the most common adverse events (greater than ...
Lecture 1- NSAIDs
... NSAIDs are group of drugs that have analgesic , antipyretic , anti-platelet & anti-inflammatory effects. They are classified according to their action on COX-enzymes into non-selective that inhibit both COX-1 & COX-2 & selective that inhibit only COX-2 enzymes. They are sharing in common therape ...
... NSAIDs are group of drugs that have analgesic , antipyretic , anti-platelet & anti-inflammatory effects. They are classified according to their action on COX-enzymes into non-selective that inhibit both COX-1 & COX-2 & selective that inhibit only COX-2 enzymes. They are sharing in common therape ...
N NITAZOXANIDE: Alinia - 2016/2017 Top 300 Pharmacy Drug Cards
... Drug Interactions: Nitazoxanide. None Adverse Reactions: Nitazoxanide Common (>10%) ...
... Drug Interactions: Nitazoxanide. None Adverse Reactions: Nitazoxanide Common (>10%) ...
Antifungal drugs
... -Antifungal spectrum includes Cryptococcus neoformans, Candida albicans, Aspergillus fumigatus, and several soil fungi which cause chromomycosis. -Resistance may arise rapidly during therapy and is an important cause of therapeutic failure when the drug is used alone. Pharmacokinetics and administra ...
... -Antifungal spectrum includes Cryptococcus neoformans, Candida albicans, Aspergillus fumigatus, and several soil fungi which cause chromomycosis. -Resistance may arise rapidly during therapy and is an important cause of therapeutic failure when the drug is used alone. Pharmacokinetics and administra ...
Product Catalog - ERFA Canada 2012 Inc.
... ATARAX is indicated in the management of anxiety and tension as in the preparation for dental procedures and in acute emotional problems. Also used in the management of anxiety associated with organic disturbances and as adjunctive therapy in alcoholism and allergic conditions with strong emotional ...
... ATARAX is indicated in the management of anxiety and tension as in the preparation for dental procedures and in acute emotional problems. Also used in the management of anxiety associated with organic disturbances and as adjunctive therapy in alcoholism and allergic conditions with strong emotional ...
Antipsychotics
... consequent risks of diabetic ketoacidosis and cardiovascular disease • The mechanism is not entirely clear, but there is evidence for both increased appetite and altered metabolic control with these drugs • Patient- related factors include pre- existing metabolic issues, and those who are obese, dia ...
... consequent risks of diabetic ketoacidosis and cardiovascular disease • The mechanism is not entirely clear, but there is evidence for both increased appetite and altered metabolic control with these drugs • Patient- related factors include pre- existing metabolic issues, and those who are obese, dia ...
Clinical Alert
... such as CV disease. Recently, the New England Journal of Medicine published results ...
... such as CV disease. Recently, the New England Journal of Medicine published results ...
use of neuromuscular blocking agents in icu
... There are probably two adverse events related to prolonged paralysis following discontinuation of NMBAs. It is defined the first, “prolonged recovery from NMBAs,” as an increase (after cessation of NMBA therapy) in the time to recovery of 50–100% longer than predicted by pharmacologic parameters. Th ...
... There are probably two adverse events related to prolonged paralysis following discontinuation of NMBAs. It is defined the first, “prolonged recovery from NMBAs,” as an increase (after cessation of NMBA therapy) in the time to recovery of 50–100% longer than predicted by pharmacologic parameters. Th ...
MIANSERIN
... • Tramadol increases the risk of seizures in patients taking an antidepressant • Carbamazepine and phenytoin may reduce mianserin levels • Theoretically could cause a fatal “serotonin syndrome” when combined with MAOIs, so do not use with MAOIs or for at least 14 days after MAOIs are stopped unless ...
... • Tramadol increases the risk of seizures in patients taking an antidepressant • Carbamazepine and phenytoin may reduce mianserin levels • Theoretically could cause a fatal “serotonin syndrome” when combined with MAOIs, so do not use with MAOIs or for at least 14 days after MAOIs are stopped unless ...
Furosemide Edema, initial dose: 20-40 mg/dose IV or IM
... Drug Usual Adult Dosage Furosemide Edema, initial dose: 20-40 mg/dose IV or IM every 2 hours as needed. Increase the dose by 20 mg every 2 hours until desired effects are seen. Edema, maintenance dosage: Give the effective dose once or twice daily. Up to 4 grams/day in patients with congestive heart ...
... Drug Usual Adult Dosage Furosemide Edema, initial dose: 20-40 mg/dose IV or IM every 2 hours as needed. Increase the dose by 20 mg every 2 hours until desired effects are seen. Edema, maintenance dosage: Give the effective dose once or twice daily. Up to 4 grams/day in patients with congestive heart ...
Table 2. Dosage regimens of injectable loop diuretics7
... Drug Usual Adult Dosage Furosemide Edema, initial dose: 20-40 mg/dose IV or IM every 2 hours as needed. Increase the dose by 20 mg every 2 hours until desired effects are seen. Edema, maintenance dosage: Give the effective dose once or twice daily. Up to 4 grams/day in patients with congestive heart ...
... Drug Usual Adult Dosage Furosemide Edema, initial dose: 20-40 mg/dose IV or IM every 2 hours as needed. Increase the dose by 20 mg every 2 hours until desired effects are seen. Edema, maintenance dosage: Give the effective dose once or twice daily. Up to 4 grams/day in patients with congestive heart ...
Management of overdose and poisoning
... At the end of NAC infusion, a blood sample should be taken for determination of the INR, plasma creatinine and ALT. If any is abnormal or the patient is symptomatic, further monitoring is required and advice sought from the NPIS Patients with normal INR, plasma creatinine and ALT and who are asympto ...
... At the end of NAC infusion, a blood sample should be taken for determination of the INR, plasma creatinine and ALT. If any is abnormal or the patient is symptomatic, further monitoring is required and advice sought from the NPIS Patients with normal INR, plasma creatinine and ALT and who are asympto ...
A combination chemotherapy trial of relapsed acute myelogenous
... (though only 2% were grade 4 i.e. >20 * ULN) and bihrubin elevations (25% of which were grade 4 i.e. >1 0 * ULN). There have been infrequent reports of seizures, nausea, and immune reactions. b. Mitoxantrone Approximately 10- 15% of patients develop cardiotoxicity manifested by arrythmias or congest ...
... (though only 2% were grade 4 i.e. >20 * ULN) and bihrubin elevations (25% of which were grade 4 i.e. >1 0 * ULN). There have been infrequent reports of seizures, nausea, and immune reactions. b. Mitoxantrone Approximately 10- 15% of patients develop cardiotoxicity manifested by arrythmias or congest ...
Calcium and Vitamin D Review - March 2015
... Medicines Management EDS2 Assessment Sheet Name: Calcium and ergocalciferol prescribing review Date considered: 2.3.15 Prior to commencing any piece of medicines management work, the following table should be completed to record the actual, or likely, impact on protected groups with consideration of ...
... Medicines Management EDS2 Assessment Sheet Name: Calcium and ergocalciferol prescribing review Date considered: 2.3.15 Prior to commencing any piece of medicines management work, the following table should be completed to record the actual, or likely, impact on protected groups with consideration of ...
Phil Rowe Reader in pharmaceutical computing School of
... creatinine is cleared quickly and blood levels remain low in renal disease creatinine levels increase. 'Creatinine clearance' therefore used as a marker of renal function. If creatinine clearance is (say) 50% of normal, then renally cleared drugs (such as gentamicin) will also be cleared at 50% of t ...
... creatinine is cleared quickly and blood levels remain low in renal disease creatinine levels increase. 'Creatinine clearance' therefore used as a marker of renal function. If creatinine clearance is (say) 50% of normal, then renally cleared drugs (such as gentamicin) will also be cleared at 50% of t ...
famotidine (fa-moe-ti-deen) - DavisPlus
... azathioprine, azithromycin, cefepime, chloramphenicol, dantrolene, diazepam, diazoxide, ganciclovir, indomethacin, pantoprazole, piperacillin/tazobactam, trimethoprim/sulfamethoxazole. ...
... azathioprine, azithromycin, cefepime, chloramphenicol, dantrolene, diazepam, diazoxide, ganciclovir, indomethacin, pantoprazole, piperacillin/tazobactam, trimethoprim/sulfamethoxazole. ...
File
... symptoms only marginally better than do placebos. Antipsychotics can reduce paranoia but may worsen confusion. Elderly patients, especially women, are at increased risk of tardive dyskinesia, which is often irreversible. The FDA has issued a warning regarding the use of atypical antipsychotics in th ...
... symptoms only marginally better than do placebos. Antipsychotics can reduce paranoia but may worsen confusion. Elderly patients, especially women, are at increased risk of tardive dyskinesia, which is often irreversible. The FDA has issued a warning regarding the use of atypical antipsychotics in th ...
NEWS YOU CAN USE 2016 01 UPD
... FDA approval for treatment of type 1 and type 2 diabetes • First insulin product approved through an ...
... FDA approval for treatment of type 1 and type 2 diabetes • First insulin product approved through an ...
Patterns of antibiotic treatment failure in pediatric community
... from the respective region for each initial index drug group (represented by colors, see legend). ...
... from the respective region for each initial index drug group (represented by colors, see legend). ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.